253 related articles for article (PubMed ID: 25168214)
21. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
[TBL] [Abstract][Full Text] [Related]
22. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
Siomin VE; Vogelbaum MA; Kanner AA; Lee SY; Suh JH; Barnett GH
J Neurooncol; 2004; 67(1-2):115-21. PubMed ID: 15072456
[TBL] [Abstract][Full Text] [Related]
23. Leptomeningeal dissemination in pediatric brain tumors.
Cocito C; Martin B; Giantini-Larsen AM; Valcarce-Aspegren M; Souweidane MM; Szalontay L; Dahmane N; Greenfield JP
Neoplasia; 2023 May; 39():100898. PubMed ID: 37011459
[TBL] [Abstract][Full Text] [Related]
24. Rehabilitation Utilization by Cancer Patients with Pathology-Confirmed Leptomeningeal Disease Receiving Intrathecal Chemotherapy.
Fu JB; Ng AH; Molinares DM; Pingenot EA; Morishita S; Silver JK; Bruera E
Am J Phys Med Rehabil; 2021 Jan; 100(1):100-104. PubMed ID: 33534219
[TBL] [Abstract][Full Text] [Related]
25. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
[TBL] [Abstract][Full Text] [Related]
26. Symptomatic leptomeningeal and intramedullary metastases from intracranial glioblastoma multiforme: a case report.
Scoccianti S; Detti B; Meattini I; Iannalfi A; Sardaro A; Leonulli BG; Martinelli F; Bordi L; Pellicanò G; Biti G
Tumori; 2008; 94(6):877-81. PubMed ID: 19267111
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis.
Yust-Katz S; Garciarena P; Liu D; Yuan Y; Ibrahim N; Yerushalmi R; Penas-Prado M; Groves MD
J Neurooncol; 2013 Sep; 114(2):229-35. PubMed ID: 23756727
[TBL] [Abstract][Full Text] [Related]
29. Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.
Kang X; Chen F; Yang SB; Wang YL; Qian ZH; Li Y; Lin H; Li P; Peng YC; Wang XM; Li WB
World J Clin Cases; 2022 Jun; 10(17):5595-5605. PubMed ID: 35979103
[TBL] [Abstract][Full Text] [Related]
30. Seizure prevalence, contributing factors, and prognostic factors in patients with leptomeningeal disease.
Zima LA; Tulpule S; Samson K; Shonka N
J Neurol Sci; 2019 Aug; 403():19-23. PubMed ID: 31176194
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
32. Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.
Suki D; Hatiboglu MA; Patel AJ; Weinberg JS; Groves MD; Mahajan A; Sawaya R
Neurosurgery; 2009 Apr; 64(4):664-74; discussion 674-6. PubMed ID: 19197219
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics and treatment of rhabdoid glioblastoma.
Babu R; Hatef J; McLendon RE; Cummings TJ; Sampson JH; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):412-9. PubMed ID: 23641829
[TBL] [Abstract][Full Text] [Related]
34. Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries.
Lamba N; Cagney DN; Catalano PJ; Elhalawani H; Haas-Kogan DA; Wen PY; Wagle N; Lin NU; Aizer AA; Tanguturi S
Neuro Oncol; 2023 May; 25(5):973-983. PubMed ID: 36367837
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma survival in the United States before and during the temozolomide era.
Johnson DR; O'Neill BP
J Neurooncol; 2012 Apr; 107(2):359-64. PubMed ID: 22045118
[TBL] [Abstract][Full Text] [Related]
36. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.
Maillie L; Salgado LR; Lazarev S
Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707
[TBL] [Abstract][Full Text] [Related]
39. Management and Outcomes in the Oldest-Old Population with Glioblastoma.
Moraes FY; Lo A; Morgan ER; Millar BA; Shultz DB; Maurice C; Harlos C; Kongkham P; Bernstein M; Zadeh G; Laperriere N; Mason W; Berlin A
Can J Neurol Sci; 2018 Mar; 45(2):199-205. PubMed ID: 29249210
[TBL] [Abstract][Full Text] [Related]
40. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.
Trifiletti DM; Romano KD; Xu Z; Reardon KA; Sheehan J
J Neurooncol; 2015 Sep; 124(3):421-7. PubMed ID: 26093620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
